Dihexa is an oligopeptide derivative evaluated in preclinical neurobiology for its high-affinity interactions with the hepatocyte growth factor (HGF) and its receptor tyrosine kinase, c-Met. Principal investigators and laboratory researchers seeking to purchase high-grade Dihexa online require rigorous analytical verification, lot-specific purity reports, and consistent synthesis standards. PX1 Research supplies USA-manufactured, research-grade Dihexa verified via high-performance liquid chromatography and mass spectrometry for in vitro and animal model investigations.
Dihexa is an oligopeptide derivative evaluated in preclinical neurobiology for its high-affinity interactions with the hepatocyte growth factor (HGF) and its receptor tyrosine kinase, c-Met. Principal investigators and laboratory researchers seeking to purchase high-grade Dihexa online require rigorous analytical verification, lot-specific purity reports, and consistent synthesis standards. PX1 Research supplies USA-manufactured, research-grade Dihexa verified via high-performance liquid chromatography and mass spectrometry for in vitro and animal model investigations.
Sourcing Dihexa online for laboratory research requires rigorous quality verification, including lot-specific HPLC purity analysis, mass spectrometry sequence confirmation, and endotoxin testing. Researchers can acquire research-grade Dihexa directly through qualified suppliers like PX1 Research, which provides USA-manufactured compounds backed by comprehensive Certificates of Analysis (COAs) for in vitro and preclinical investigation.
When evaluating options for a Dihexa purchase, academic and private laboratories must prioritize batch reproducibility and chemical integrity. In vitro cellular assays and structural signaling experiments depend on high chemical purity (>98%) to eliminate confounding variables caused by residual synthesis reagents, truncated peptide fragments, or bacterial endotoxins. Procurement teams should verify that every batch is accompanied by third-party documentation issued by an ISO 17025 accredited laboratory prior to experimental deployment.
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic oligopeptide derivative designed as a low-molecular-weight mimetic of hepatocyte growth factor (HGF). Originally synthesized to overcome the poor stability and limited tissue permeability associated with large native protein ligands, Dihexa exhibits distinct physicochemical properties that make it a compelling subject of study in structural biology.
With a molecular mass of approximately 502.7 g/mol, Dihexa possesses enhanced lipophilicity compared to canonical peptide sequences. In vitro biochemical characterization demonstrates that this molecular configuration allows the compound to maintain stability in physiological buffers while preserving strong binding affinities for its target domain. Researchers investigating peptide mimetics frequently reference the unique structural architecture of Dihexa when designing experiments focused on growth factor amplification and receptor dimerization.
The primary biochemical target of Dihexa is the hepatocyte growth factor (HGF) / c-Met receptor tyrosine kinase signaling axis. Preclinical studies suggest that Dihexa binds to native HGF with picomolar affinity, stabilizing the bioactive conformation of HGF and facilitating receptor dimerization. Upon binding, the c-Met receptor undergoes autophosphorylation, initiating downstream signaling cascades critical for cellular survival, differentiation, and structural remodeling.
In vitro data indicate that activation of the HGF/c-Met pathway by Dihexa triggers intracellular signaling through both the phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK)/ERK pathways. These downstream effectors regulate cytoskeletal dynamics, gene expression, and protein synthesis necessary for dendritic spine formation and neurite outgrowth. Understanding these molecular interactions allows researchers to map out structural neuroplasticity mechanisms in controlled cell culture models.
In preclinical models of neurobiology, Dihexa has been evaluated for its potential to stimulate synaptogenesis—the formation of new functional synaptic connections between neurons. Rodent models of cognitive decline and neurodegeneration demonstrate that incubation or administration of Dihexa correlates with a measurable increase in dendritic spine density and the restoration of post-synaptic density markers such as PSD-95 and synaptophysin.
In vitro assays using primary hippocampal and cortical neuronal cultures show that low-nanomolar concentrations of Dihexa promote extensive neurite elongation and arborization. These findings suggest that the compound enhances intrinsic neurogenic mechanisms without requiring direct genetic modification of target cells. Researchers continue to utilize Dihexa in baseline comparative studies examining how small-molecule mimetics induce rapid structural plasticity across diverse neuronal populations.
To contextualize the signaling profile of Dihexa, investigators frequently compare its receptor binding dynamics against other well-characterized neuroactive compounds within our broader research peptides collection. While Dihexa exerts its primary activity via HGF/c-Met receptor dimerization, compounds like Semax act predominantly through melanocortin receptors and brain-derived neurotrophic factor (BDNF) up-regulation. Similarly, Selank modulates GABAergic neurotransmission and enkephalin degradation, whereas BPC-157 influences focal adhesion kinase and VEGFR2 pathways in tissue repair models.
This divergence in molecular targets makes Dihexa a distinct tool for researchers contrasting HGF-mediated plastic responses against BDNF or neurovascular signaling cascades. Cross-referencing these pathways in comparative assay protocols provides a more comprehensive understanding of how different peptide structures regulate neuronal architecture, survival, and network connectivity in preclinical models.
Maintaining rigorous quality control is critical when purchasing research peptides online. PX1 ResearchSubjects every lot of Dihexa to a comprehensive analytical testing regimen prior to distribution. Purity is quantitatively established using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline chemical purity exceeding 98%. Chromatograms are provided to verify the absence of structural isomers or residual synthesis side-products.
Molecular identity is validated using Electrospray Ionization Mass Spectrometry (ESI-MS), confirming that the observed mass-to-charge ratio matches the theoretical molecular weight of Dihexa exactly. Furthermore, because bacterial contamination can alter cellular physiological responses in sensitive bioassays, every lot undergoes Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain below stringent research thresholds (<0.01 EU/µg). Researchers can access these findings directly on our dedicated PX1 research hub.
Due to its hydrophobic N-hexanoic moiety, Dihexa exhibits distinct solubility characteristics compared to highly hydrophilic peptides. For in vitro laboratory applications, solubilization in high-purity dimethyl sulfoxide (DMSO) or ethanol is typically recommended to prepare a concentrated master stock solution before diluting into aqueous assay media or balanced salt solutions.
When preparing working solutions, researchers should perform reconstitution under aseptic conditions within a certified laminar flow biosafety cabinet. Once dissolved in a primary organic solvent, stock solutions can be diluted into phosphate-buffered saline (PBS) or culture media, maintaining solvent concentrations at levels non-toxic to cell cultures (typically <0.1% v/v DMSO). Gentle vortexing or mild bath sonication may be applied to ensure complete dissolution without causing peptide shear stress.
Lyophilized Dihexa exhibits excellent long-term stability when stored under appropriate environmental conditions. Upon receipt, unopened vials should be stored in a freezer at -20°C for short-to-medium term storage, or at -80°C for extended archival periods. Desiccation precautions should be maintained to prevent moisture condensation on the lyophilized cake during temperature equilibration.
Reconstituted liquid stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles. Stored liquid aliquots at -20°C maintain analytical stability for several weeks, provided they are shielded from direct light exposure. Adhering to these storage standards ensures consistent concentration accuracy and baseline reactivity across long-term experimental timelines.
PX1 Research serves as a trusted primary supplier for academic institutions, biotechnology firms, and contract research organizations worldwide. All peptides provided by PX1 Research are manufactured in state-of-the-art facilities located within the United States, adhering strictly to ISO 9001 and GMP-compliant quality management standards. Every single lot is independently verified by third-party ISO 17025 accredited analytical laboratories.
To support high-throughput screening and large-scale experimental designs, we offer institutional accounts and bulk purchasing through our wholesale peptide supply portal. Combined with same-day dispatch from our California and Arizona fulfillment centers for orders placed Monday through Friday, PX1 Research provides the supply-chain reliability and uncompromising purity required for modern scientific discovery.
What primary signaling receptor does Dihexa target in laboratory research?
Dihexa functions primarily as a high-affinity ligand for hepatocyte growth factor (HGF), potentiating HGF binding to the c-Met receptor tyrosine kinase and driving downstream PI3K/Akt and MAPK/ERK activation in cellular models.
What purity level is guaranteed when ordering Dihexa from PX1 Research?
PX1 Research provides Dihexa with a guaranteed chemical purity of >98% as determined by Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and verified via mass spectrometry.
How is Dihexa shipped to ensure chemical stability during transit?
Dihexa is shipped as a highly stable, lyophilized (freeze-dried) powder. Orders are processed with fast transit times from our California and Arizona facilities to preserve compound integrity.
What solvent is recommended for dissolving Dihexa for cell culture assays?
Because of its hydrophobic hexanoic acid chain, Dihexa is best dissolved initially in high-purity laboratory-grade DMSO or ethanol to create a concentrated stock solution before further dilution into aqueous buffers or cell culture media.
Does PX1 Research provide analytical documentation with every shipment?
Yes. Every lot of Dihexa is accompanied by a batch-specific Certificate of Analysis (COA) containing raw RP-HPLC chromatograms, mass spectrometry reports, and endotoxin assay data.
How does Dihexa differ structurally from endogenous HGF?
Dihexa is a small oligopeptide mimetic (approx. 502.7 g/mol) synthesized to replicate the receptor-activating effects of native HGF, which is a massive ~80 kDa multi-domain protein ligand.
What are the recommended long-term storage conditions for lyophilized Dihexa?
Unopened lyophilized Dihexa should be stored desiccated at -20°C or -80°C to preserve chemical stability and prevent degradation over extended storage periods.
Can academic and corporate research facilities establish institutional accounts for bulk ordering?
Yes, PX1 Research offers institutional supply programs, bulk tiers, and custom synthesis support through our dedicated wholesale portal for verified research entities.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.